A physiologically based pharmacokinetic model of diethyl phthalates in humans. [PDF]
Chen S, Shi Z, Zhang Q.
europepmc +1 more source
Physiologically-based pharmacokinetic model for CAR-T cells delivery and efficacy in solid tumors
Hadjigeorgiou AG +3 more
europepmc +1 more source
Meta-Analysis of the Input and Disposition of Various Dosage Forms of Methylprednisolone in Healthy Subjects Utilizing a Physiologically Based Pharmacokinetic Model. [PDF]
Yu R, Jusko WJ.
europepmc +1 more source
Prediction of SPT-07A Pharmacokinetics in Rats, Dogs, and Humans Using a Physiologically-Based Pharmacokinetic Model and In Vitro Data. [PDF]
Zhu X, Kong W, Wang Z, Liu X, Liu L.
europepmc +1 more source
Whole Body Physiologically Based Pharmacokinetic Model to Explain A Patient With Drug-Drug Interaction Between Voriconazole and Flucloxacillin. [PDF]
Abdullah-Koolmees H +9 more
europepmc +1 more source
Development of a physiologically-based pharmacokinetic model to simulate the pharmacokinetics of intramuscular antiretroviral drugs. [PDF]
Bettonte S +4 more
europepmc +1 more source
Development of a physiologically-based pharmacokinetic model for Ritonavir characterizing exposure and drug interaction potential at both acute and steady-state conditions. [PDF]
Ngo LT +5 more
europepmc +1 more source
Physiologically Based Pharmacokinetic Model for Long-Circulating Inorganic Nanoparticles
A physiologically based pharmacokinetic model was developed for accurately characterizing and predicting the in vivo fate of long-circulating inorganic nanoparticles (NPs).
Zhi Ping Xu, Xiaowen Liang
exaly +3 more sources
Definition and validation of a patient-individualized physiologically-based pharmacokinetic model [PDF]
Pharmacokinetic modeling based on a mechanistic approach is a promising tool for drug concentration prediction in living beings. The development of a reduced physiologically-based pharmacokinetic model (PBPK model), is performed by lumping organs and ...
Mario Grassi +2 more
exaly +2 more sources

